Find similar content

Source channel @githubtrending · Post #15072 · Aug 18

#other#automation#automation_templates#integration#n8n#n8n_automation#n8n_template#no_code_ai#no_code_automation#workflow_automation You can use a large collection of ready-made automation templates for n8n, an open-source, low-code workflow automation tool that connects over 350 apps. These templates help automate tasks like email labeling, social media posting, document processing, chatbots, and data analysis without needing to build workflows from scratch. This saves you time and effort by letting you quickly implement smart automations for business, marketing, support, and more. n8n’s visual editor and AI integrations make it easy to customize workflows, improving your productivity and operational efficiency with minimal coding. https://github.com/enescingoz/awesome-n8n-templates

Hashtags

#other #automation #automation_templates #integration #n8n #n8n_automation #n8n_template #no_code_ai #no_code_automation #workflow_automation

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment